Shares of YIDU TECH (02158) climbed nearly 8% in early trading on the Hong Kong Stock Exchange, before easing to a gain of 5.97% at HK$4.435 per share, with turnover reaching HK$17.07 million at the time of writing.

In August, the Key Laboratory for Clinical Big Data Standardization and Integrated Application was officially established at China-Japan Friendship Hospital, following approval from the National Health Commission. As a national-level platform, the laboratory is dedicated to advancing clinical big data standardization, while also exploring high-quality dataset construction and collaborative efforts in medical artificial intelligence across industry, academia, and research sectors. The recent formation of its first academic committee signals a new phase in the laboratory's development.

Notably, YIDU TECH has built a comprehensive, end-to-end capability chain spanning "data governance, AI-Ready processing, model training and evaluation, and AI agent applications," supported by its data and knowledge middle platforms, a high-quality dataset refinement platform, a model and intelligent agent development platform, and an AI agent application platform. In alignment with the laboratory's focus areas, including clinical big data standardization, high-quality datasets, and medical AI, YIDU TECH plans to deepen its collaboration with China-Japan Friendship Hospital, leveraging its technical expertise and practical experience in medical data governance and medical AI to jointly explore pathways for using high-quality medical data in scientific research innovation and AI-driven applications.